Compounds, compositions and methods for treating degenerative diseases and disorders are disclosed, the compounds having the following structure (I): 1 including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein R.sub.1 and R.sub.2 are as defined herein.